Clinical Trial Detail

NCT ID NCT02080260
Title A Study of Regorafenib in Advanced Pancreatic Cancer Patients
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements no
Sponsors Stuart Salmon
Indications

pancreatic adenocarcinoma

Therapies

Regorafenib

Age Groups: adult

No variant requirements are available.